[Ganglionic-blocking agents. 9].
D008725:Bis-Trimethylammonium Compounds / Q000627:therapeutic use; D002712:Chlorides; D002714:Chlorisondamine / Q000627:therapeutic use; D005730:Ganglionic Blockers / Q000627:therapeutic use*; D006584:Hexamethonium Compounds / Q000627:therapeutic use; D006801:Humans; D008464:Mecamylamine / Q000627:therapeutic use; D010393:Pempidine / Q000627:therapeutic use; D010425:Pentolinium Tartrate / Q000627:therapeutic use; D000644:Quaternary Ammonium Compounds / Q000627:therapeutic use; D013757:Tetraethylammonium Compounds / Q000627:therapeutic use
D008725:Bis-Trimethylammonium Compounds; D002712:Chlorides; D005730:Ganglionic Blockers; D006584:Hexamethonium Compounds; D000644:Quaternary Ammonium Compounds; D013757:Tetraethylammonium Compounds; D008464:Mecamylamine; D010425:Pentolinium Tartrate; D002714:Chlorisondamine; D010393:Pempidine
Ganglienblocker. 9.